Skip to main content
    I

    Invivyd Inc. (IVVD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.54
    -0.04 (-7.63%)

    Market Cap: $171.58M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Invivyd Inc. (IVVD) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Invivyd (IVVD) trades at 2.9x sales and 1.2x book value. Its P/B of 1.2x is in line with its 5-year median. Its forward P/E is 7.0x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E7.0x
    Price to sales2.9x
    Price to book1.2x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/B1.2x1.2xN/A
    Medians of month-end values through Oct 2026: 60 months (5-year).

    Valuation History

    Over the 3 of the 5 year ends shown that have a P/S, its P/S ranged from 2.1x in 2024 to 143.1x in 2023.

    Year endPriceP/SP/B
    2025$2.476.7x1.8x
    2024$0.442.1x0.8x
    2023$3.94143.1x2.4x
    2022$1.50N/A0.5x
    2021$7.26N/A0.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IVVD

    What is IVVD's forward P/E ratio?

    Invivyd has a forward P/E ratio of 7.0x.

    Is IVVD stock overvalued?

    GNG's valuation label for IVVD is Undervalued.

    What is IVVD's price to sales ratio?

    Invivyd has a price to sales ratio of 2.9x.